CDCガイドラインの使い方 感染対策

出版社: メディカ出版
著者:
発行日: 2019-02-25
分野: 看護学  >  臨床/成人/老人
ISBN: 9784840468541
電子書籍版: 2019-02-25 (電子書籍版)
書籍・雑誌
≪全国送料無料でお届け≫
発送目安:4~8営業日

3,300 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

3,300 円(税込)

商品紹介

「CDCガイドラインは知っているけれど、どのように使えばいいのかな?」「説得材料として使いたいけれど、よくわからない」と悩むあなたのために、朝から晩までCDCガイドラインについて考えている矢野先生がクスっと笑える“たとえ話”をまじえてバッチリ解説!知ってて当たり前のCDCガイドラインを実践で生かすためのノウハウが満載!

目次

  • 【1 SSIガイドライン】
    〔Point of View1〕期末試験の勉強はいつ始める?
             [予防抗菌薬の投与はいつ開始する?]
    〔Point of View2〕期末試験の勉強はいつまで続ける?
             [予防抗菌薬の追加投与はいつまで続ける? ]
    〔Point of View3〕今日の体重、どこまで許せる?何kgから~何kgまで?
             [周術期の血糖の目標値は?]
    〔Point of View4〕庭の草取りをしていて、蚊に刺されても平気?
             [人間の体内の異物]
    〔Point of View5〕シャワーや入浴を我慢すると風邪を引かない?
             [創部を消毒しても大丈夫?]

    【2 血管内カテーテルガイドライン】
    〔Point of View1〕公衆トイレには掃除専門のスタッフが常駐すべきか?
             [血管内カテーテルの交換の頻度は?]
    〔Point of View2〕電車に乗車するときには、自宅を何時に出発したらよいか?
             [クロルヘキシジンの濃度はどうすればいい?]
    〔Point of View3〕スケルトン製品は人気がある!
             [カテーテルの挿入部位を観察しよう]
    〔Point of View4〕ラーメンのどんぶりはどのようにして洗う?
             [輸液ラインのアクセス部分の消毒はどうする?]
    〔Point of View5〕車の運転中に信号が赤になったら、停まれ!
             [マキシマル・バリアプリコーションは必要!]

    【3 ノロウイルスアウトブレイクのガイドライン】
    〔Point of View1〕ボルダリングとノロウイルスの関係は?
             [ノロウイルス免疫]
    〔Point of View2〕ノロウイルスのキーワードは「48時間」
             [ノロウイルス胃腸炎と接触予防策]

    【4 尿道カテーテルガイドライン】
    〔Point of View1〕冷蔵庫を定期的に買い替えない
             [尿道留置カテーテルは定期交換する?]
    〔Point of View2〕そうめんやキャベツは細いほうが美味しい
             [尿道カテーテルは細いほうがいい]
    〔Point of View3〕砂埃のなかを運転するときには窓を閉める
             [尿道留置カテーテルは閉鎖式?]
    〔Point of View4〕水が淀むとゴミが溜まる
             [カテーテルやチューブ内の尿流は停滞させない]
    〔Point of View5〕三種の神器!
             [尿道留置カテーテルは便利だけど……]

    【5 隔離予防策ガイドライン】
    〔Point of View1〕人を見たら泥棒と思え!
             [標準予防策をすべての人に!]
    〔Point of View2〕大型台風が来たら、家の補強をしよう!
             [感染経路別予防策は標準予防策に加えよう!]
    〔Point of View3〕未来を予測しよう! 占いは当たるか?
             [標準予防策では曝露の予想が必要!]
    〔Point of View4〕秋刀魚を食べるとき、飼い犬の散歩のとき
             [個人防護具の使用後の処理が大変だ!]
    〔Point of View5〕空気を読む人、作る人とは?
             [空気感染隔離室では空気の管理が必要]

    【6 結核ガイドライン】
    〔Point of View1〕ベジタリアンとペスクタリアンとは?
             [結核菌は空気感染しかしない(つまりビーガン的)]
    〔Point of View2〕フィットテストとシールチェック
             [フィットテストとシールチェックって何?]
    〔コラム〕フィットテスト
    〔Point of View3〕空気感染隔離室=トイレ?
             [空気感染隔離室って?]
    〔Point of View4〕芽を摘む
             [潜在性結核感染の治療のターゲットは?]
    〔コラム〕潜在性結核感染の治療

    【7 院内肺炎ガイドライン】
    〔Point of View1〕野山の露(=人工呼吸器の結露)は汚い?
             [結露は汚い!]
    〔Point of View2〕挿管時のチューブ内の分泌物=2階のトイレの汚水?
             [分泌物の取り扱いは厳重に!]
    〔Point of View3〕アフリカ旅行時の発熱=ICUでの発熱
             [ICUには耐性菌がウヨウヨ]
    〔Point of View4〕周囲の人々から嫌われる人とは?
             [気管内挿管は感染対策では嫌われている]
    〔Point of View5〕ゴルフの腕前は練習回数に比例する?
             [人工呼吸器の呼吸回路は定期交換しない!]

    【8 環境制御ガイドライン】
    〔Point of View1〕「手指の接触面」はシンプル・イズ・ベスト
             [環境表面の分類は簡単に]
    〔コラム〕選挙の候補者
    〔Point of View2〕キウイやスイカは野菜? 果物?
             [医療器具を三つに分類しよう]
    〔Point of View3〕あなたのストーブは何畳用?
             [アルコールの消毒範囲は狭い!]
    〔Point of View4〕子どもが鼻血を出しても慌てない
             [血液が床にこぼれたとき]
    〔Point of View5〕カーペットには微生物が潜んでいる!
             [病院の床のカーペット]

    【9 手指衛生ガイドライン】
    〔Point of View1〕森林公園のトイレの悲劇
             [正しい手指衛生とは]
    〔Point of View2〕外科医は料理をしてはならない
             [手術時手洗いはアルコールで!]
    〔コラム〕指輪が外せない


    【10 透析ガイドライン】
    〔Point of View1〕人は城、人は石垣、人は堀
             [透析室のHBV感染対策は厳重に!]
    〔Point of View2〕新幹線のトイレの床に直接座ることができる?
             [「標準予防策」と「透析室の感染対策」]
    〔Point of View3〕的外れな対策とは?
             [透析室のHCV、HIV対策は適切に!]

    【11 血液曝露ガイドライン群】
    〔Point of View1〕いつまでも若くない!
             [若い人はHBs抗体を獲得しやすい]
    〔Point of View2〕増税と一発屋芸人
             [HBVワクチンのブースト]
    〔Point of View3〕HBV ワクチンは昔取った杵柄
             [HBs抗体価が低下しても大丈夫]
    〔コラム〕数学の天才少年
    〔Point of View4〕感染した医師は原因を思い起こすことができない
             [知らない間のHBV曝露]
    〔Point of View5〕コンサート入場までの道のりとHBVの針刺し対策
             [HBVの曝露後の対応]
    〔Point of View6〕選択肢は一つのほうがいい
             [HIVの曝露後予防は1種類だけ!]
    〔Point of View7〕なんでも短いほうがいい!
             [HIVのフォローアップ期間は短めに!]
    〔コラム〕HIV スクリーニング検査のウインドウ期

    【12 インフルエンザワクチン推奨群】
    〔Point of View1〕何でも割り勘がよい!
             [重症卵アレルギーとインフルエンザワクチン]
    〔Point of View2〕母から子どもへの0歳のプレゼント
             [母親から新生児への最大のプレゼントは免疫である]
    〔Point of View3〕二兎を追う者は一兎をも得ず
             [小児へのインフルエンザワクチン]

おすすめ商品

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1 SSIガイドライン

P.21 掲載の参考文献
1) CDC. Guideline for prevention of surgical site infection, 2017. https://www.cdc.gov/infectioncontrol/guidelines/ssi/index.html
2) CDC. Guideline for prevention of surgical site infection, 1999. https://www.cdc.gov/hai/pdfs/ssiguidelines.pdf
3) WHO. Global guidelines for the prevention of surgical site infection. http://www.who.int/gpsc/global-guidelines-web.pdf
6) Rogers, DM. et al. Povidone-iodine wound irrigation and wound sepsis. Surg Gynecol Obstet. 157 (5), 1983, 426-30.
7) Sindelar, WF. et al. Randomised trial of intraperitoneal irrigation with low molecular weight povidone-iodine solution to reduce intra-abdominal infectious complications. J Hosp Infect. 6, 1985, SupplA : 103-14.
8) Sindelar, WF. et al. Intraperitoneal irrigation with povidone-iodine solution for the prevention of intra-abdominal abscesses in the bacterially contaminated abdomen. Surg Gynecol Obstet. 148 (3), 1979, 409-11.
9) Chang, FY. et al. Can povidone-iodine solution be used safely in a spinal surgery? Eur Spine J. 15 (6), 2006, 1005-14.

2 血管内カテーテルガイドライン

P.36 掲載の参考文献
1) CDC. Guidelines for the prevention of intravascular catheter-related infections, 2011. http://www.cdc.gov/hicpac/pdf/guidelines/bsi-guidelines-2011.pdf
2) Pearson, ML. Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections : an overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 24 (4), 1996, 262-77.
3) CDC. Guidelines for the prevention of intravascular catheter-related infections, 2002. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5110a1.htm
4) Van Donk, P. et al. Routine replacement versus clinical monitoring of peripheral intravenous catheters in a regional hospital in the home program : a randomized controlled trial. Infect Control Hosp Epidemiol. 30 (9), 2009, 915-7.
6) Webster, J. et al. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 17 (3), 2010, CD007798.
7) Lai, KK. Safety of prolonging peripheral cannula and i.v. tubing use from 72 hours to 96 hours. Am J Infect Control. 26 (1),1998, 66-70.
8) Garland, JS. et al. Peripheral intravenous catheter complications in critically ill children : a prospective study. Pediatrics. 89, 1992, 1145-50.
9) Garland, JS. et al. Infectious complications during peripheral intravenous therapy with Teflon catheters : a prospective study. Pediatr Infect Dis J. 6 (10), 1987, 918-21.
10) Eyer S, et al. Catheter-related sepsis : prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med. 18 (10), 1990, 1073-9.
11) Uldall, PR. et al. Changing subclavian haemodialysis cannulas to reduce infection. Lancet. 1 (8234), 1981, 1373.
13) Snydman, DR. et al. Intravenous tubing containing burettes can be safely changed at 72 hour intervals. Infect Control. 8 (3), 1987, 113-6.
14) Maki, DG. et al. Prospective study of replacing administration sets for intravenous therapy at 48-vs 72hour intervals. 72 hours is safe and cost-effective. JAMA. 1987, 258 (13), 1777-81.
15) Josephson, A. et al. The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infect Control. 6 (9), 1985, 367-70.
18) Maki, DG. et al. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 338 (8763), 1991, 339-43.
19) Chaiyakunapruk, N. et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care : a meta-analysis. Ann Intern Med. 2002, 136 (11), 792-801.
20) Maki, DG. et al. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. Gauze, a transparent polyurethane dressing, and an iodophortransparent dressing. JAMA. 258 (17), 1987, 2396-403.
21) Menyhay, SZ. et al. Preventing central venous catheter-associated bloodstream infections : development of an antiseptic barrier cap for needleless connectors. Am J Infect Control. 36 (10) : (Suppl 174), 2008, e1-5.
22) Sherertz, RJ. et al. Education of physiciansin-training can decrease the risk for vascular catheter infection. Ann Intern Med. 132 (8), 2000, 641-8.

3 ノロウイルスアウトブレイクのガイドライン

P.44 掲載の参考文献
1) MacCannell T, et al. Guideline for the prevention and control of norovirus gastroenteritis outbreaks in healthcare settings. Infect Control Hosp Epidemiol. 2011, 32 (10), 939-69. http://www.cdc.gov/hicpac/pdf/norovirus/Norovirus-Guideline-2011.pdf
2) Graham DY, et al. Norwalk virus infection of volunteers : new insights based on improved assays. J Infect Dis. 170 (1), 1994, 34-43.

4 尿道カテーテルガイドライン

P.56 掲載の参考文献
1) CDC. Guideline for prevention of catheter-associated urinary tract infections,2009. https://www.cdc.gov/infectioncontrol/pdf/guidelines/cauti-guidelines.pdf
2) Wong, ES. Guideline for prevention of catheter-associated urinary tract infections. Am J Infect Control. 11 (1), 1983, 28-36.

5 隔離予防策ガイドライン

P.68 掲載の参考文献

6 結核ガイドライン

P.80 掲載の参考文献
1) CDC. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005). http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5417a1.htm http://www.cdc.gov/mmwr/PDF/rr/rr5417.pdf
2) CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in healthcare facilities, 1994. MMWR. 43 (No. RR-13), 1994.
3) The Vegetarian Society. FAQs About vegetarianism. https://www.vegsoc.org/FAQs
4) American Thoracic Society, CDC, Infectious Disease Society of America. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med. 161 (4 Pt 1), 2000, 1376-95.
5) American Thoracic Society, CDC, and Infectious Disease Society of America. Treatment of tuberculosis. MMWR. 52 (No. RR-11), 2003.
6) D'Agata EM, et al. Nosocomial transmission of Mycobacterium tuberculosis from an extrapulmonary site. Infect Control Hosp Epidemiol. 22 (1), 2001, 10-2.
7) Keijman J, et al. Unusual nosocomial transmission of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis. 20 (11), 2001, 808-9.
8) CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. http://www.cdc.gov/mmwr/PDF/rr/rr4906.pdf
9) American Thoracic Society, CDC. Update : adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection---United States, 2003. MMWR. 52 (31), 2003, 735-9.

7 院内肺炎ガイドライン

P.95 掲載の参考文献
1) CDC. Guidelines for preventing health-care-associated pneumonia, 2003. https://www.cdc.gov/infectioncontrol/guidelines/pdf/guidelines/healthcare-associated-pneumonia.pdf
2) CDC. Guideline for prevention of nosocomial pneumonia. https://www.cdc.gov/mmwr/preview/mmwrhtml/00045365.htm
3) Craven DE, et al. Contaminated condensate in mechanical ventilator circuits. A risk factor for nosocomial pneumonia? Am Rev Respir Dis. 129 (4), 1984, 625-8.
6) Craven DE, et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis. 133 (5), 1986, 792-6.
7) Kotilainen HR, et al. Cost analysis and clinical impact of weekly ventilator circuit changes in patients in intensive care unit. Am J Infect Control. 25, 1997, 117-20.
8) Long MN, et al. Prospective, randomised study of ventilator-associated pneumonia in patients with one versus three ventilator circuit changes per week. Infect Control Hosp Epidemiol. 17 (1), 1996, 14-9.
9) Hess D, et al. Weekly ventilator circuit changes. A strategy to reduce costs without affecting pneumonia rates. Anesthesiology. 82 (4), 1995, 903-11.
10) Dreyfuss D, et al. Prospective study of nosocomial pneumonia and of patient and circuit colonization during mechanical ventilation with circuit changes every 48 hours versus no change. Am Rev Respir Dis. 143 (4 Pt 1), 1991, 738-43.
11) Kollef MH, et al. Mechanical ventilation with or without 7-day circuit changes. A randomized controlled trial. Ann Intern Med. 123 (3), 1995, 168-74.
12) Fink JB, et al. Extending ventilator circuit change interval beyond 2 days reduces the likelihood of ventilator-associated pneumonia. Chest. 113 (2), 1998, 405-11.

8 環境制御ガイドライン

P.108 掲載の参考文献
1) CDC. Guidelines for environmental infection control in health-care facilities, 2013. https://www.cdc.gov/infectioncontrol/pdf/guidelines/environmental-guidelines.pdf
2) CDC. Guideline for handwashing and hospital environmental control, 1985. https://wonder.cdc.gov/wonder/prevguid/p0000412/p0000412.asp
3) CDC. Guidelines for prevention of nosocomial pneumonia,1997. https://www.cdc.gov/mmwr/preview/mmwrhtml/00045365.htm
4) Anderson RL. Biological evaluation of carpeting. Appl Microbiol. 18 (2), 1969, 180-7.
5) Lanese RR, et al. A study of microflora on tiled and carpeted surfaces in a hospital nursery. Am J Public Health. 63 (2), 1973, 174-8.
6) Suzuki A, et al. Bacterial contamination of floors and other surfaces in operating rooms : a five-year survey. J Hyg (Lond). 93 (3), 1984, 559-66.
7) Anderson RL, et al. Carpeting in hospitals : An epidemiological evaluation. J Clin Microbiol. 15 (3), 1982, 408-15.
8) Gerson SL, et al. Aspergillosis due to carpet contamination. Infect Control Hosp Epidemiol. 15 (4 Pt 1), 1994, 221- 3.

9 手指衛生ガイドライン

P.118 掲載の参考文献
1) CDC. Guideline for hand hygiene in health-care settings. https://www.cdc.gov/mmwr/PDF/rr/rr5116.pdf
2) CDC. Guideline for handwashing and hospital environmental control. https://wonder.cdc.gov/wonder/prevguid/p0000412/p0000412.asp

10 透析ガイドライン

P.129 掲載の参考文献
1) CDC. Recommendations for Preventing Transmission of Infections Among Chronic Hemodialysis Patients. http://www.cdc.gov/mmwr/PDF/rr/rr5005.pdf
2) Favero MS, et al. Hepatitis-B antigen on environmental surfaces [Letter]. Lancet. 2 (7843), 1973, 1455.
3) Bond WW, et al. Survival of hepatitis B virus after drying and storage for one week [Letter]. Lancet. 1 (8219), 1981, 550-1.
4) Alter MJ, et al. Impact of infection control strategies on the incidence of dialysis-associated hepatitis in the United States. J Infect Dis. 153 (6), 1986, 1149-51.
5) Najem GR, et al. Control of hepatitis B infection : The role of surveillance and an isolation hemodialysis center. JAMA. 245 (2), 1981, 153-7.

11 血液曝露ガイドライン群

P.153 掲載の参考文献
1) CDC. Guideline for infection control in health care personnel, 1998. http://www.cdc.gov/hicpac/pdf/infectcontrol98.pdf
2) Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis, 2001. http://www.cdc.gov/mmwr/PDF/rr/rr5011.pdf
3) CDC. Recommendations for preventing transmission of infections among chronic hemodialysis patients, 2001. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5005a1.htm
4) CDC. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States, 2006. http://www.cdc.gov/mmwr/PDF/rr/rr5516.pdf
5) CDC. Guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management, 2013. http://www.cdc.gov/mmwr/pdf/rr/rr6210.pdf
7) CDC. Viral Hepatitis : Hepatitis C information. https://www.cdc.gov/hepatitis/hcv/profresourcesc.htm
8) 飯野四郎. 組換え沈降B形肺炎ワクチン (酵母由来, HBX-R) の第三相試験成績. 薬理と治療. 15 (6), 1987, 2403-15.
9) 厚労省. B型肝炎ワクチンの定期接種が始まります! (ポスター) http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000134156.pdf
10) Callender ME, et al. Hepatitis B virus infection in medical and health care personnel. Br Med J. 284 (6312), 1982, 324-6.
11) Chaudhuri AK, et al. Hepatitis B virus infection in medical and health care personnel. Br Med J. 284 (6326), 1982, 1408.
12) Garibaldi RA, et al. Nonparenteral serum hepatitis : Report of an outbreak. JAMA. 220 (7), 1972, 963-6.
13) Rosenberg JL, et al. Viral hepatitis : an occupational hazard to surgeons. JAMA. 223 (4), 1973, 395-400.
14) Bond WW, et al. Survival of hepatitis B virus after drying and storage for one week. Lancet. 1 (8219), 1981, 550-1.
16) Favero MS, et al. HepatitisB antigen on environmental surfaces. Lancet. 2 (7843), 1973, 1455.
17) Lauer JL, et al. Transmission of hepatitis B virus in clinical laboratory areas. J Infect Dis. 140 (4), 1979, 513-6.
18) Updated US Public Health Service Guidelines for the management of occupational exposures to HIV and Recommendations for postexposure prophylaxis. http://www.cdc.gov/mmwr/PDF/rr/rr5409.pdf
19) エイズ治療・研究開発センター : HIV感染症の診断. http://www.acc.ncgm.go.jp/doctor/diagnosis/010/diacrisis.html

12 インフルエンザワクチン推奨群

P.165 掲載の参考文献
1) CDC. Prevention and control of influenza with vaccines : Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011. http://www.cdc.gov/mmwr/pdf/wk/mm6033.pdf
2) CDC. Prevention and control of seasonal influenza with vaccines : Recommendations of the Advisory Committee on Immunization Practices-United States, 2016-17 Influenza Season. http://www.cdc.gov/mmwr/volumes/65/rr/pdfs/rr6505.pdf
4) CDC. Prevention and control of seasonal influenza with vaccines : Recommendations of the Advisory Committee on Immunization Practices-United States, 2013-2014. https://www.cdc.gov/mmwr/pdf/rr/rr6207.pdf
5) CDC. Pregnant women & influenza (Flu). https://www.cdc.gov/flu/protect/vaccine/pregnant.htm
6) ACIP Recommendations and Pregnancy (Flu). https://www.cdc.gov/vaccines/pregnancy/hcp-toolkit/acip-recs.html
7) Pool V, et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol. 194 (4), 2006, 1200, author reply 1201.
8) 厚生労働省. 平成28年版厚生労働白書-人口高齢化を乗り越える社会モデルを考える-. http://www.mhlw.go.jp/wp/hakusyo/kousei/16/backdata/02-01-01-03.html
9) CDC. Prevention and control of seasonal influenza with Vaccines : Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season. https://www.cdc.gov/mmwr/volumes/67/rr/pdfs/rr6703a1-H.pdf

最近チェックした商品履歴

Loading...